Latest News about REGN
Recent news which mentions REGN
   1 Small-Cap Stock With 10X Potential
   
  
  
  October 27, 2021
  From Motley Fool
 
   The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
   
  
  
  October 24, 2021
  From Benzinga
 From Motley Fool
 From Benzinga
 
   Biotech Buyouts That Would Be Great for Investors
   
  
  
  October 22, 2021
  From Motley Fool
 
   Will Merck's COVID-19 Pill Sink Regeneron's and Eli Lilly's Antibody Therapy Sales?
   
  
  
  October 22, 2021
  From Motley Fool
 
   The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO
   
  
  
  October 21, 2021
  From Benzinga
 From Benzinga
 
   The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs
   
  
  
  October 18, 2021
  From Benzinga
 
   2 Best Biotech Stocks to Buy Right Now
   
  
  
  October 18, 2021
  From Motley Fool
 
   3 No-Brainer Biotech Stocks to Buy Right Now
   
  
  
  October 16, 2021
  From Motley Fool
 
   Why Shares of Allogene Therapeutics, Beam Therapeutics, Intellia Therapeutics, and Schrödinger Are Volatile This Week
   
  
  
  October 15, 2021
  From Motley Fool
 
   2 Cheap Growth Stocks That Could Be Even Better Buys in November
   
  
  
  October 15, 2021
  From Motley Fool
 
   90,000 U.S. adult deaths from COVID-19 over the summer could have been prevented if victims had been vaccinated, study finds
   
  
  
  October 14, 2021
  From MarketWatch
 
   Pfizer Just Scored Another Key Regulatory Approval
   
  
  
  October 14, 2021
  From Motley Fool
 
   3 Biotech Stocks You Can Buy and Hold for the Next Decade
   
  
  
  October 13, 2021
  From Motley Fool
 
   AstraZeneca's COVID-19 Therapy Hits Goal In Phase 3 Trial
   
  
  
  October 11, 2021
  From Benzinga
 
   Why Humana Is Suing Biogen
   
  
  
  October 09, 2021
  From Motley Fool
 
   Regeneron Could Have a Big Catalyst Coming in 2022
   
  
  
  October 09, 2021
  From Motley Fool
 
   Cramer Likes DraftKings, Skyworks, And These Automakers
   
  
  
  October 07, 2021
  From Benzinga
 
   Is This The Turning Point for Inovio?
   
  
  
  October 06, 2021
  From Motley Fool
 
   Tesla and Merck Give Investors Some Hope
   
  
  
  October 04, 2021
  From Benzinga
 
   3 Stocks That Might Soar With Pills for COVID
   
  
  
  October 03, 2021
  From Motley Fool
 
   Here Are the Leaders in the Race to Develop a COVID-19 Pill
   
  
  
  October 03, 2021
  From Motley Fool
 From Benzinga
 From MarketWatch
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
